Evidence map›Paper›PMID 41385120›Full record

ReviewMedical oncology (Northwood, London, England)2025

Characteristic of Aldosterone-Producing adrenocortical carcinoma: review of the literature.

Francesco Arcidiacono, Bianca Pellegrini, Antonio Prinzi, Ignazio Barca, Concita Trischitta, Rosario Pivonello, Pasqualino Malandrino, Maria Cristina De Martino

Abstract readReview
PubMed Publisher
In one paragraph

Review in Medical oncology (Northwood, London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Primary aldosteronism.Nature reviews. Disease primers · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Francesco Arcidiacono *Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Catania, Garibaldi-Nesima Medical Center, Catania, 95122, Italy. francescoarcidiacono.fa@gmail.com.ORCID http://orcid.org/0009-0006-0183-624X
Bianca Pellegrini *Dipartimento di Medicina Clinica e Chirurgia, Università Federico II di Napoli, Naples, Italy.
Antonio PrinziEndocrinology Unit, Department of Clinical and Experimental Medicine, University of Catania, Garibaldi-Nesima Medical Center, Catania, 95122, Italy.
Ignazio BarcaEndocrinology Unit, Department of Clinical and Experimental Medicine, University of Catania, Garibaldi-Nesima Medical Center, Catania, 95122, Italy.
Concita TrischittaDipartimento di Medicina Clinica e Chirurgia, Università Federico II di Napoli, Naples, Italy.
Rosario PivonelloDipartimento di Medicina Clinica e Chirurgia, Università Federico II di Napoli, Naples, Italy.
Pasqualino MalandrinoEndocrinology Unit, Department of Clinical and Experimental Medicine, University of Catania, Garibaldi-Nesima Medical Center, Catania, 95122, Italy.
Maria Cristina De MartinoDipartimento di Medicina Clinica e Chirurgia, Università Federico II di Napoli, Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adrenocortical carcinoma (ACC) is a rare tumor, and aldosterone-producing-ACCs are even less frequent. Data on aldosterone-producing ACC (APAC) are scarce and most of the current knowledge derives from case reports. Therefore, aiming to summarize the main clinical features described in this aggressive cancer, we conducted a review of the PubMed database on this topic from 2005 to 2024. We included only studies with histological confirmation of ACC and biochemical evidence of aldosterone hypersecretion, identifying 27 reported cases of APAC. Epidemiological and radiological features of APACs resemble those of ACCs in general, whereas the median Ki67 index appears higher (25% vs. 10-14%) and the prevalence of ENSAT stage I greater (18% vs. 5-6%) compared with the overall ACC population, although a meaningful comparison would require a specifically designed prospective study. This is the first review assessing Ki67 and ENSAT stage in APACs based on previously published cases. To date, no significant differences have been described in morphological, clinical, or molecular aspects between these two types of ACC. Larger and higher-quality studies are needed to confirm these findings.

Indexed as

Adrenal Cortex NeoplasmsAdrenocortical CarcinomaAldosteroneFemaleHumansKi-67 AntigenAldosteroneKi-67 AntigenAdrenocortical carcinomaAldosteroneAldosterone-producing adrenocortical carcinomaAPACENSATKi67

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.